Mirviss Jeffrey B. insider trades
Mirviss Jeffrey B. has filed 45 Form 4s with the SEC that we hold, for Boston Scientific Corp (BSX) (EVP&Pres, Periph Intervent) and CONMED Corp (CNMD) (Director). Across all of them we count 0 purchases worth $0 and 28 sales worth $18.2M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 63,802 shares of Boston Scientific Corp worth $4.8M, dated 2024-05-29. The first filing on our record is dated 2021-07-27 and the latest 2026-07-02.
Boston Scientific Corp (BSX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-07-27 | S, sale reported on Form 4 | 6,748 | $305.1K | 2021-07-27 |
| 2022-01-04 | S, sale reported on Form 4 | 6,840 | $297.8K | 2022-01-05 |
| 2022-03-22 | S, sale reported on Form 4 | 11,236 | $500.0K | 2022-03-23 |
| 2022-04-19 | S, sale reported on Form 4 | 10,989 | $500.0K | 2022-04-20 |
| 2022-04-20 | S, sale reported on Form 4 | 9,645 | $448.5K | 2022-04-21 |
| 2022-12-09 | S, sale reported on Form 4 | 41,032 | $1.9M | 2022-12-12 |
| 2022-12-12 | S, sale reported on Form 4 | 11,080 | $518.0K | 2022-12-13 |
| 2023-01-04 | S, sale reported on Form 4 | 6,751 | $313.1K | 2023-01-04 |
| 2023-02-16 | S, sale reported on Form 4 | 1,409 | $65.9K | 2023-02-21 |
| 2023-02-17 | S, sale reported on Form 4 | 2,061 | $95.5K | 2023-02-21 |
| 2023-02-21 | S, sale reported on Form 4 | 2,313 | $107.1K | 2023-02-22 |
| 2023-02-22 | S, sale reported on Form 4 | 3,340 | $154.0K | 2023-02-22 |
| 2023-03-30 | S, sale reported on Form 4 | 4,903 | $243.2K | 2023-03-31 |
| 2023-04-05 | S, sale reported on Form 4 | 4,903 | $247.1K | 2023-04-06 |
| 2023-08-28 | S, sale reported on Form 4 | 13,971 | $742.4K | 2023-08-30 |
| 2023-08-29 | S, sale reported on Form 4 | 4,657 | $253.8K | 2023-08-30 |
| 2023-12-06 | S, sale reported on Form 4 | 353 | $19.4K | 2023-12-07 |
| 2024-01-03 | S, sale reported on Form 4 | 11,931 | $689.9K | 2024-01-04 |
| 2024-01-04 | S, sale reported on Form 4 | 15,000 | $876.0K | 2024-01-05 |
| 2024-01-09 | S, sale reported on Form 4 | 15,172 | $898.9K | 2024-01-10 |
| 2024-02-21 | S, sale reported on Form 4 | 4,960 | $329.1K | 2024-02-22 |
| 2024-03-18 | S, sale reported on Form 4 | 14,506 | $963.9K | 2024-03-19 |
| 2024-05-29 | S, sale reported on Form 4 | 63,802 | $4.8M | 2024-05-30 |
| 2025-01-03 | S, sale reported on Form 4 | 7,152 | $642.7K | 2025-01-03 |
| 2025-02-12 | S, sale reported on Form 4 | 13,022 | $1.4M | 2025-02-13 |
| 2025-02-19 | S, sale reported on Form 4 | 1,510 | $159.1K | 2025-02-19 |
| 2025-02-24 | S, sale reported on Form 4 | 4,675 | $487.4K | 2025-02-25 |
| 2025-02-25 | S, sale reported on Form 4 | 2,688 | $279.6K | 2025-02-25 |
CONMED Corp (CNMD)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1566094) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms